Search research articles
Contact Us
Filters
Showing results (81-90 of 153) with videos related to
Page
of 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2005
Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2
Purva Bali, Michael Pranpat, Ramona Swaby, et al.
Blood
|
April 20, 2002
Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis
Fei Guo, Ramadevi Nimmanapalli, Shanthi Paranawithana, et al.
Journal of Lipid Research
|
November 20, 2012
Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene
Tara Ann Burns, Marimuthu Subathra, Paola Signorelli, et al.
Cancer Research
|
January 9, 2003
Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis
Sylvie Wittmann, Purva Bali, Sreenivasa Donapaty, et al.
Blood
|
October 30, 2004
Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3
Prince George, Purva Bali, Srinivas Annavarapu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90
Warren Fiskus, Yuan Ren, Alex Mohapatra, et al.
Journal of Immunological Methods
|
September 8, 2004
Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening
Maura Gasparetto, Tracy Gentry, Said Sebti, et al.
Journal of Family Medicine and Primary Care
|
December 22, 2021
Association of psychosocial factors with aggression among school going rural adolescents in Haryana
Ramesh Verma, Gopal Kumar, Rohtas Kanwar Yadav, et al.
The Journal of Biological Chemistry
|
June 7, 2005
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors
Purva Bali, Michael Pranpat, James Bradner, et al.
Cancer Research
|
August 28, 2003
Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells
Ramadevi Nimmanapalli, Lianne Fuino, Purva Bali, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 153) with videos related to
Sort By:
Page
of 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2005
Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2
Purva Bali, Michael Pranpat, Ramona Swaby, et al.
Blood
|
April 20, 2002
Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis
Fei Guo, Ramadevi Nimmanapalli, Shanthi Paranawithana, et al.
Journal of Lipid Research
|
November 20, 2012
Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene
Tara Ann Burns, Marimuthu Subathra, Paola Signorelli, et al.
Cancer Research
|
January 9, 2003
Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis
Sylvie Wittmann, Purva Bali, Sreenivasa Donapaty, et al.
Blood
|
October 30, 2004
Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3
Prince George, Purva Bali, Srinivas Annavarapu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90
Warren Fiskus, Yuan Ren, Alex Mohapatra, et al.
Journal of Immunological Methods
|
September 8, 2004
Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening
Maura Gasparetto, Tracy Gentry, Said Sebti, et al.
Journal of Family Medicine and Primary Care
|
December 22, 2021
Association of psychosocial factors with aggression among school going rural adolescents in Haryana
Ramesh Verma, Gopal Kumar, Rohtas Kanwar Yadav, et al.
The Journal of Biological Chemistry
|
June 7, 2005
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors
Purva Bali, Michael Pranpat, James Bradner, et al.
Cancer Research
|
August 28, 2003
Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells
Ramadevi Nimmanapalli, Lianne Fuino, Purva Bali, et al.
Page
of 16